http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2284812-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2a930c6bd47ce6ea6dd26f2f1a42b0c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02
filingDate 2005-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3df643aa258a7a760865e6b3958fa7cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d0982a206f3e7d8a4d9717072d4d9d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9c19cb2489426a23f75740f36d8cbad
publicationDate 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2284812-C1
titleOfInvention Method for treating proliferative vitreoretinopathy
abstract FIELD: medicine, pharmacology. n SUBSTANCE: one should perform tamponade of vitreal cavity with perfluoroorganic compound (PFOC) and retinal endolasercoagulation followed by substitution of PFOC for silicone oil which should be removed at the term of 1-6 mo, moreover, after retinal endolasercoagulation one should introduce 0.3-0.5 ml medicinal preparation into vitreal cavity and while removing PFOC this preparation should be remained upon retinal surface. Application of medicinal preparation at declared volume between PFOC and silicone oil provides steady distribution of medicinal preparation above retina, and silicone tamponade inhibits ocular withdrawal of preparation, thus, enhancing its pharmacological action. n EFFECT: higher efficiency of therapy. n 4 dwg, 1 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2634684-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2662903-C1
priorityDate 2005-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ899Y1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8D4Y9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74483
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9KRJ0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP43153
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9X721
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ56696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31307
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ46085
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP43154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505112

Total number of triples: 30.